80 related articles for article (PubMed ID: 17385060)
21. Human INT6 interacts with MCM7 and regulates its stability during S phase of the cell cycle.
Buchsbaum S; Morris C; Bochard V; Jalinot P
Oncogene; 2007 Aug; 26(35):5132-44. PubMed ID: 17310990
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the interaction between the interferon-induced protein P56 and the Int6 protein encoded by a locus of insertion of the mouse mammary tumor virus.
Guo J; Sen GC
J Virol; 2000 Feb; 74(4):1892-9. PubMed ID: 10644362
[TBL] [Abstract][Full Text] [Related]
23. The Bad, the Good and eIF3e/INT6.
Sesen J; Casaos J; Scotland SJ; Seva C; Eisinger-Mathason TS; Skuli N
Front Biosci (Landmark Ed); 2017 Jan; 22(1):1-20. PubMed ID: 27814599
[TBL] [Abstract][Full Text] [Related]
24. An oncogenic role of eIF3e/INT6 in human breast cancer.
Grzmil M; Rzymski T; Milani M; Harris AL; Capper RG; Saunders NJ; Salhan A; Ragoussis J; Norbury CJ
Oncogene; 2010 Jul; 29(28):4080-9. PubMed ID: 20453879
[TBL] [Abstract][Full Text] [Related]
25. The INT6 cancer gene and MEK signaling pathways converge during zebrafish development.
Grzmil M; Whiting D; Maule J; Anastasaki C; Amatruda JF; Kelsh RN; Norbury CJ; Patton EE
PLoS One; 2007 Sep; 2(9):e959. PubMed ID: 17895999
[TBL] [Abstract][Full Text] [Related]
26. eIF3 targets cell-proliferation messenger RNAs for translational activation or repression.
Lee AS; Kranzusch PJ; Cate JH
Nature; 2015 Jun; 522(7554):111-4. PubMed ID: 25849773
[TBL] [Abstract][Full Text] [Related]
27. Somatic mutations that contribute to breast cancer.
Callahan R
Biochem Soc Symp; 1998; 63():211-21. PubMed ID: 9513725
[TBL] [Abstract][Full Text] [Related]
28. Functional genetic screen for genes involved in senescence: role of Tid1, a homologue of the Drosophila tumor suppressor l(2)tid, in senescence and cell survival.
Tarunina M; Alger L; Chu G; Munger K; Gudkov A; Jat PS
Mol Cell Biol; 2004 Dec; 24(24):10792-801. PubMed ID: 15572682
[TBL] [Abstract][Full Text] [Related]
29. Int6/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2alpha expression.
Chen L; Endler A; Uchida K; Horiguchi S; Morizane Y; Iijima O; Toi M; Shibasaki F
Circulation; 2010 Aug; 122(9):910-9. PubMed ID: 20713899
[TBL] [Abstract][Full Text] [Related]
30. Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e).
Mayeur GL; Hershey JW
FEBS Lett; 2002 Mar; 514(1):49-54. PubMed ID: 11904180
[TBL] [Abstract][Full Text] [Related]
31. Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis.
Garnis C; Campbell J; Davies JJ; Macaulay C; Lam S; Lam WL
Hum Mol Genet; 2005 Feb; 14(4):475-82. PubMed ID: 15615770
[TBL] [Abstract][Full Text] [Related]
32. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
33. Essential role of TID1 in maintaining mitochondrial membrane potential homogeneity and mitochondrial DNA integrity.
Ng AC; Baird SD; Screaton RA
Mol Cell Biol; 2014 Apr; 34(8):1427-37. PubMed ID: 24492964
[TBL] [Abstract][Full Text] [Related]
34. PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer.
Ling G; Ahmadian A; Persson A; Undén AB; Afink G; Williams C; Uhlén M; Toftgård R; Lundeberg J; Pontén F
Oncogene; 2001 Nov; 20(53):7770-8. PubMed ID: 11753655
[TBL] [Abstract][Full Text] [Related]
35. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon.
Zinda MJ; Johnson MA; Paul JD; Horn C; Konicek BW; Lu ZH; Sandusky G; Thomas JE; Neubauer BL; Lai MT; Graff JR
Clin Cancer Res; 2001 Aug; 7(8):2475-9. PubMed ID: 11489829
[TBL] [Abstract][Full Text] [Related]
36. Loss of Tid1/DNAJA3 Co-Chaperone Promotes Progression and Recurrence of Hepatocellular Carcinoma after Surgical Resection: A Novel Model to Stratify Risk of Recurrence.
Chen KY; Huang YH; Teo WH; Chang CW; Chen YS; Yeh YC; Lee CJ; Lo JF
Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33406664
[TBL] [Abstract][Full Text] [Related]
37. Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease.
Okamoto N; Tanaka A; Jung K; Karasawa K; Orito K; Matsuda A; Amagai Y; Oida K; Ohmori K; Matsuda H
Cardiovasc Res; 2011 Nov; 92(2):209-17. PubMed ID: 21771896
[TBL] [Abstract][Full Text] [Related]
38. Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer.
Dong Z; Zhang JT
Crit Rev Oncol Hematol; 2006 Sep; 59(3):169-80. PubMed ID: 16829125
[TBL] [Abstract][Full Text] [Related]
39. Expression of mdm-2 oncoprotein in the primary and metastatic sites of mammary tumor (GI-101) implanted athymic nude mice.
Rathinavelu P; Malavé A; Raney SR; Hurst J; Roberson CT; Rathinavelu A
Cancer Biochem Biophys; 1999 Jul; 17(1-2):133-46. PubMed ID: 10738909
[TBL] [Abstract][Full Text] [Related]
40. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H
Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
